Fig. 6
Case 4: CA125 levels during the treatment course. Short-term relugolix therapy has resulted in a significant decrease in CA125 levels
Fig. 6 | BMC Women's Health
Case 4: CA125 levels during the treatment course. Short-term relugolix therapy has resulted in a significant decrease in CA125 levels